InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Vounatsos Michel, 首席执行官. Officer active across 4 companies, notably Perkinelmer INC. Aggregated, 11 filings have been recorded. History available since 7 May 2021. The latest transaction was filed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Vounatsos Michel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
10,831 股0American Depositary SharesSEC:0000905148-25-002220:0
1,074 股0Common StockSEC:0000950170-25-061826:0
21,253 股0American Depositary SharesSEC:0000905148-24-001751:0
977 股0Common StockSEC:0000950170-24-052069:0
783 股0Common StockSEC:0000950170-23-022714:0
18,332 股0American Depositary SharesSEC:0000899243-23-007332:0
610 股0Common StockSEC:0000899243-22-017248:0
6,191 股0Common StockSEC:0001127602-22-006280:0
4,321 股0Common StockSEC:0001127602-22-004986:0
10,594 股0Common StockSEC:0001127602-22-001859:0
604 股0Common StockSEC:0000899243-21-018993:0
11 条申报中的 11 条
About Vounatsos Michel
Michel Vounatsos is the Chief Executive Officer and Board Member at PERKINELMER INC and BIOGEN INC. In these roles, he oversees the operations and strategy of the companies, bringing expertise in the biopharmaceutical sector. Michel contributes to innovation and growth through his strategic vision.
